Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis

Clinical and Experimental Immunology

Volumn 110, Issue 2, 1997, Pages 203-211

  Rafati, S ^a   Couty Jouve, S ^b   Alimohammadian, M H ^a   Louis, J A ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Biochemical analysis of amastigote soluble antigens; Cutaneous leishmaniasis; Interferon gamma and IL 4 evaluation

Indexed keywords

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IMMUNOGENICITY; LEISHMANIA MAJOR; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

EID: 0030730738     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.tb08318.x     Document Type: Article

References (43)

1. Locksley RM, Louis JA. Immunology of leishmaniasis. Curr Opin Immunol 1992; 4:413-8.
2. Melby CP. Experimental leishmaniasis: review. Rev Infect Dis 1991; 13:1009-17.
3. + T cells in intracellular infections in humans: leishmaniasis as an example. Immunol Today 1996; 17:13-16.
4. Peters W, Killick-Kendrick R. The leishmaniasis in biology and medicine clinical aspects and control. Vol. III. New York: Academic Press, 1987.
5. Modabber F. Development of vaccines against leishmaniasis. Scand J Infect Dis Supplement 1990; 76:72-78.
6. WHO. Technical report series 793. Geneva: 1990.
7. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13:151-77.
8. Bratscher P, Wei G, Menon J, Bickfeldt-Ohman H. Establishment of stable cell-mediated immunity that makes susceptible mice resistance to Leishmania major. Science 1992; 257:539-42.
9. Wang ZE, Zheng S, Corry DB, Dalton DK, Seder RA, Reiner SL, Locksley RM. Interferon γ independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci USA 1994; 91:12932-6.
10. Bogdan C, Rollinghoff M. The impact of the type 1 and type 2 T helper cell concept on novel vaccine design with emphasis on protection against Leishmania parasites In: Kaufmann SHE, ed. Concepts in vaccine development. Berlin: Walter de Gruyter 1996:143-180.
11. Sharton-Kersten Afonso LCC, Wysocka M, Trinchieri G, Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol 1995; 154:5320-30.
12. + T cell response. J Exp Med 1995; 181:961-71.
13. Reed SG, Scott P. T cell and cytokine responses in leishmaniasis. Curr Opin Immunol 1993; 5:524-31.
14. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigen. J Exp Med 1988; 168:1675-84.
15. Diego Miralles G, Stoecke MY, McDermott DF, Finkelman FD, Murray HW. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun 1993; 3:1058-63.
16. Russo DM, Jardim EM, Carvalho EM, Sleath PR, Armitage RJ, Olafson RW, Reed SG. Mapping human T cell epitopes in Leishmania gp63. Identification of cross-reactive and species specific epitopes. J Immunol 1993; 150:932-9.
17. Molyneux DH, Ashford RW. The biology of Trypanosoma and Leishmania, parasite of man and domestic animals. London: Academic Press, 1983:192-194.
18. Wilson ME, Young BM, Katherine PA, Weinstock JV, Metwali A, Ali KM, Donelson JE. A recombinant Leishmania chagasi antigen. Infect Immun 1995; 5:2062-9.
19. Louis JA, Moedder E, Behin R, Engers H. Recognition of protozoan parasite antigens by murine T lymphocytes. Eur J Immunol 1979; 9:871-47.
20. Glaser TA, Humphris DC, Mukkada AJ. Leishmania major and L. donavani: a method for rapid purification of amastigote. Exp Parasitol 1990; 71:343-5.
21. Scott P, Pearce E, Natovitz P, Sher A. Vaccination against cutaneous leishmaniasis in murine model II. Immunological properties of protective and non protective subfractions of a soluble promastigotes extract. J Jmmunol 1987; 139:3118-25.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
23. Ausubel F, Brent R. Short protocols in molecular biology, 3rd edn. New York: Wiley 1995.
24. Pupkis MF, Tetley L, Coombs GH. Leishmania mexicana: amastigote hydrolyses in unusual lysosomes. Exp Parasitol 1986; 62:29-39.
25. Zilberstein D. Adaptation of Leishmania species to an acidic environment. Biochem Parasitol, Taylor and Francis 1991:349-66.
26. Bates PA. Axenic culture of Leishmania amastigotes. Parasitol Today 1993; 9:143-6.
27. McKerrow JH. Parasite proteases. Exp Parasitol 1989; 68:111-5.
28. North MJ, Mottram JC, Coombs GH. Cysteine proteinases of parasitic protozoa. Parasitol Today 1990; 6:270-5.
29. Coombs GH, Baxter J. Inhibition of Leishmania amastigote growth by antipain and leupeptin. Ann Trop Med Parasitol 1984; 78:21-24.
30. Titus RG, Theodos CM, Shanker A, Hall LR. Interaction between Leishmania major and macrophages. In: Zwilling T, Elisenstein T, eds. Macrophage-pathogen interaction. New York: Marcel Dekker, 1993:437-59.
31. Chang KP, Fong D, Bray RS. The biology of Leishmania and leishmaniasis. In: Chang KP, Bray ES, eds. Leishmaniasias. Amesterdam: Elsivier, 1985:1-30.
32. Mukkada AJ, Meade JC, Glaser TA, Bonventre PF. Enhanced metabolism of Leishmania donovani amastigotes at acid pH: an adaptation for intercellular growth. Science 1985; 229:1099-101.
33. Robertson CD, Coombs GH. Characterization of three groups of cysteine proteinases in the amastigotes of Leishmania mexicana mexicana. Mol Biochem Parasitol 1990; 42:269-76.
34. Lackwood BC, North MJ, Mallison DJ, Coombs GH. Analysis of Leishmania proteinases reveals developmental changes in species-specific forms and a common 68 kDa activity. FEMS Microbiol Letters 1987; 48:345-50.
35. North MJ, Cooms GH. Proteinases of Leishmania mexicana amastigotes and promastigotes analysis by gel electrophoresis. Mol Biochem Parasitol 1981; 3:293-300.
36. Ilg T, Fuch M, Gnau V, Wolfram M, Harbecke D, Overath P. Distribution of parasite cysteine proteinases in lesions of mice infected with Leishmania mexicana amastigotes. Mol Biochem Parasitol 1994; 67:193-203.
37. Robertson CD, Coombs GH. Stage specific proteinases of Leishmania mexicana mexicana promastigotes. FEMS Microbiology Letters 1992; 94:127-32.
38. McMahon-Pratt D, Jaffe CL, Kahl L, Langer P, Lohman K, Pan A, Rivas L. Characterization of developmentally regulated molecules of Leishmania host-parasite cellular and molecular interaction in protozoal infection. In: Chang KP, Snary D, eds. Biochemistry of parasite. Berlin: Springer-Verlag 1987:123-36.
39. Mottram JC, Robertson CD, Coombs GH, Barry JD. A developmentally regulated cysteine proteinase gene of Leishmania mexicana. Mol Microbiol 1992; 6:1925-32.
40. North MJ, Lackwood BC, Mallinson DJ, Coombs GH. Proteolysis in Leishmania: species differences and developmental change in proteinase activity. In: Hart DT, ed. Leishmaniasis - The current status and new strategies for control. NATO ASI Series. New York: Plenum Press 1987; 163:635-42.
41. Melby PC, Sacks DL. Identification of antigens recognized by T cells in human leishmaniasis: analysis of T cells clones by immunoblotting. Infect Immun 1989; 57:2971-6.
42. Kurtzhals JAL, Hey AS, Jardim A et al. Dichotomy of the human T cell response to Leishmania antigen II. Absent or Th2 like response to gp63 and Th1 like response to LPG associated protein in cells from cured visceral leishmaniasis patients. Clin Exp Immunol 1994; 96:416-21.
43. Melby PC, Andrade-Narvaez FJ, Darnell BJ, Valencia-Pacheco G, Tryon VU, Palomo-Cetina A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect Immun 1994; 62:8837-42.